Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
516 Results Found
Study finds depression, anxiety raise risk of adverse cardiac event
Depression and anxiety can increase the risk of a major adverse cardiac event, according to an American Heart Association study published Dec. 17.
Blog: Putting 340B Program Growth in Context
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.
Report finds increasing concentration in commercial health, MA insurance markets
The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly concentrated in 2024.
CMS says nearly 950,000 enrolled for new Marketplace coverage
Approximately 950,000 consumers who currently do not have health insurance coverage through the federally facilitated Health Insurance Marketplace have signed up for a 2026 health plan, the Centers for Medicare & Medicaid Services announced Dec. 5.
Dueling Senate bills to address health care affordability fail to pass
The Senate today failed to pass legislation to address health care affordability. The chamber first voted on a Republican-backed bill that failed by a 51-48 vote. The bill would have disbursed $1,000 in health spending accounts for individuals age 18-49 and $1,500 for those age 50-64. A Democrat-led plan that would have extended the enhanced premium tax credits for three years also failed by a 51-48 tally. The bills needed 60 votes to pass.
CMS issues state guidance on Medicaid community engagement requirements
The Centers for Medicare & Medicaid Services released guidance Dec. 8 for states implementing Medicaid community engagement requirements outlined by the budget reconciliation bill.
U.S. reaches trade agreement with U.K. on drug pricing
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In exchange, the U.K. will increase the net price it pays for new medicines by 25%.
AHA, others file suit to block unlawful 340B changes threatening patient care
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District Court for the District of Maine to challenge the 340B Rebate Model Pilot Program.
CMS announces latest negotiated prices for 15 drugs to begin in 2027
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations under the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.